Pharmacology
News
Psilocybin matches SSRI for moderate to severe depression in phase 2 study
“It’s very clear that psilocybin therapy has a faster antidepressant onset than escitalopram,” said lead author Robin Carhart-Harris, PhD.
News
Transgender hormone therapy linked to blood pressure changes
BP elevations in transgender males and a subset of transgender females are seen before and soon after gender-affirming hormone therapy initiation...
News
GENUINE improvements: Ublituximab plus ibrutinib for CLL
News
Study shows how COVID-19 disrupted RA meds
Early COVID-19 restrictions significantly altered medication and management patterns among RA patients.
News
Survey finds Mohs surgeons favor nicotinamide for chemoprevention
Overall, 76.9% of the respondents said they recommended nicotinamide for preventing KC, and 20% said they had recommended nicotinamide to more...
News
FDA approves frontline immunotherapy for gastric cancers
Nivolumab is now approved for the frontline treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal...
News
How some COVID-19 vaccines could cause rare blood clots
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
Conference Coverage
Adjunctive MDMA safe, effective for severe PTSD
"The most interesting part of the study is that the Adverse Childhood Experiences scale had no effect," noted Dr. Bessel van der Kolk.
News
New guidelines on antibiotic prescribing focus on shorter courses
News
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...